Modulation of neural stem cells by use of EGFL7 or EGFL7 antagonists

Scientists from the university hospital of Frankfurt am Main prove for the first time, that the signalling protein EGFL7 binds to notch receptors and regulates the self renewal of neural stem cells. Therefore, EGFL7, EGFL7 antagonists and EGFL7 antibodies can be used to grow specialised cells and tissues from neural stem cells and to treat lesions and neurodegenerative diseases of the central nervous system.

Further Information: PDF

INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/798-49721

Dr. Otmar Schöller

Media Contact TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Creating good friction: Pitt engineers aim to make floors less slippery

Swanson School collaborators Kurt Beschorner and Tevis Jacobs will use a NIOSH award to measure floor-surface topography and create a predictive model of friction. Friction is the resistance to motion…

Synthetic tissue can repair hearts, muscles, and vocal cords

Scientists from McGill University develop new biomaterial for wound repair. Combining knowledge of chemistry, physics, biology, and engineering, scientists from McGill University develop a biomaterial tough enough to repair the…

Constraining quantum measurement

The quantum world and our everyday world are very different places. In a publication that appeared as the “Editor’s Suggestion” in Physical Review A this week, UvA physicists Jasper van…

Partners & Sponsors